Skip to main navigation Skip to search Skip to main content

Estimating Changes in Medicare Part D and Commercial Insurer Insulin Spending Amid Planned State-Led Biosimilar Insulin Production in California

Research output: Contribution to journal › Article › peer-review

Original languageEnglish (US)
Pages (from-to)734-735
Number of pages2
JournalJAMA Internal Medicine
Volume183
Issue number7
DOIs
StatePublished - Jul 3 2023

ASJC Scopus subject areas

  • Internal Medicine

Cite this